William Schuyler Jones

William Schuyler Jones

Associate Professor of Medicine

I am an interventional cardiologist with a specific focus on the diagnosis and treatment of patients with cardiovascular disease. As a clinician, I see patients in the office and do coronary and peripheral vascular procedures (angiography and interventions) in the Duke Cardiac Catheterization Laboratory. I have served as the Medical Director of the cath lab at Duke since 2016. Alongside my partners in the cath lab, we collaborate with our cardiothoracic surgeons to hold Heart Team meetings each week, and we frequently are asked to address complex cardiovascular issues as a multidisciplinary team.

I also have a broad background in cardiovascular site-based research, multicenter clinical trials, clinical event classification, and observational analyses. I have helped to lead clinical trial efforts at the Duke Clinical Research Institute (DCRI) by designing and conducting studies evaluating new and existing treatments for patients with coronary artery disease and peripheral artery disease. My specific research interests include examining access to care and disparities in care for patients with peripheral artery disease and the design and conduct of pragmatic clinical trials in cardiovascular disease.

Appointments and Affiliations

  • Associate Professor of Medicine
  • Associate Professor in Population Health Sciences
  • Member in the Duke Clinical Research Institute

Contact Information

  • Office Location: 2400 Pratt Street, 7037, Durham, NC 27705
  • Office Phone: (919) 668-8917
  • Email Address: schuyler.jones@duke.edu

Education

  • Duke University, 2005
  • Duke University, 2004
  • M.D. University of Arkansas, Little Rock, 2001

Representative Publications

  • Amin, KD; Weissler, EH; Ratliff, W; Sullivan, AE; Holder, TA; Bury, C; Francis, S; Theiling, BJ; Hintze, B; Gao, M; Nichols, M; Balu, S; Jones, WS; Sendak, M, Development and Validation of a Natural Language Processing Model to Identify Low-Risk Pulmonary Embolism in Real Time to Facilitate Safe Outpatient Management., Annals of Emergency Medicine (2024) [10.1016/j.annemergmed.2024.01.036] [abs].
  • Marquis-Gravel, G; Stebbins, A; Wruck, LM; Roe, MT; Effron, MB; Hammill, BG; Whittle, J; VanWormer, JJ; Robertson, HR; Alikhaani, JD; Kripalani, S; Farrehi, PM; Girotra, S; Benziger, CP; Polonsky, TS; Merritt, JG; Gupta, K; McCormick, TE; Knowlton, KU; Jain, SK; Kochar, A; Rothman, RL; Harrington, RA; Hernandez, AF; Jones, WS, Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease., Journal of the American Heart Association, vol 13 no. 4 (2024) [10.1161/JAHA.122.026921] [abs].
  • Rymer, J; Alhanti, B; Kemp, S; Bhatt, DL; Kochar, A; Angiolillo, DJ; Diaz, M; Garratt, KN; Wimmer, NJ; Waksman, R; Kirtane, AJ; Ang, L; Bach, R; Barker, C; Jenkins, R; Basir, MB; Sullivan, A; El-Sabae, H; Brothers, L; Ohman, EM; Jones, WS; Washam, JB; Wang, TY, Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO Registry, Journal of the Society for Cardiovascular Angiography and Interventions, vol 3 no. 2 (2024) [10.1016/j.jscai.2023.101202] [abs].
  • Ganta, VC; Jones, WS; Annex, BH, A conundrum of arterialized capillaries and vascular dilation in chronic limb-threatening ischaemia., European Heart Journal, vol 45 no. 4 (2024), pp. 265-267 [10.1093/eurheartj/ehad826] [abs].
  • Mehta, H; Chan, W-C; Aday, AW; Jones, WS; Parmar, GM; Hance, K; Thors, A; Alli, A; Wiley, M; Tadros, P; Gupta, K, Outcomes of peripheral artery disease and polyvascular disease in patients with end-stage kidney disease., Journal of Vascular Surgery (2024) [10.1016/j.jvs.2024.01.016] [abs].